Kenneth Keller

Kenneth Keller

Director/Board Member at AMBIT BIOSCIENCES CORP
63 year
Health Technology
Consumer Services

Profile

Kenneth Joseph Keller is currently Chairman, President & Chief Executive Officer at Daiichi Sankyo, Inc. since 2014.
Mr. Keller is also Director at Ambit Biosciences Corp.
since 2014.
Mr. Keller serves as Director & Head-Oncology Business Unit at Daiichi Sankyo Co., Ltd. starting in 2021.
Formerly, Mr. Keller was President & Chief Executive Officer at American Regent, Inc. from 2016 to 2021.
Mr. Keller was Chief Operating Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2012 to 2014.
Mr. Keller earned an MBA from Loyola Marymount University and completed undergraduate studies at St. John's University.

Kenneth Keller active positions

CompaniesPositionStart
AMBIT BIOSCIENCES CORP Director/Board Member 10/11/2014
DAIICHI SANKYO COMPANY, LIMITED Director/Board Member 01/06/2025
Chief Executive Officer 01/03/2014

Former positions of Kenneth Keller

CompaniesPositionEnd
Chief Executive Officer 01/04/2021
SPECTRUM PHARMACEUTICALS, INC. Chief Operating Officer 17/04/2014
See the detail of Kenneth Keller's experience

Training of Kenneth Keller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Kenneth Keller
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!